Posted on Aug 17, 2017
Revise Update: March 26, 2026
Guest Author: Brian Rivera
Contrary to what many people think, SEC for monoclonal antibodies isn’t plug-and-play. It should be simple, after all, size exclusion chromatography is supposed to be a non-adsorptive, size-based separation, right? Pick a column, run a standard buffer like 1X PBS, and you are good to go. In theory, yes. In reality, it's not quite.
For SEC to behave ideally, the separation must be completely entropic, meaning analytes separate purely by hydrodynamic size with minimal electrostatic or hydrophobic interaction with the stationary phase. Monoclonal antibodies are a special situation, as reducing both secondary ion exchange and hydrophobic interactions is a tall order. Secondary interactions show up, peak shape suffers, recovery drops, and suddenly a “simple” SEC method turns into a full-scale method-development exercise.
And when you are dealing with aggregate analysis, that matters. SEC methods for mAbs are typically quantitative, so anything that affects recovery or peak integrity directly impacts your data.
Understanding Secondary Interactions in SEC
Monoclonal antibodies are large (~150 kDa), structurally complex molecules with heterogeneous surfaces. Many therapeutic mAbs have relatively high isoelectric points, which means they often carry a net positive charge under neutral buffer conditions.
Increasing ionic strength in the mobile phase often helps suppress electrostatic effects, but there is a balancing act: too much salt can promote salting-out behavior, making hydrophobic aggregates even stickier. Additives such as low levels of organic modifiers, arginine, or specific chaotropic salts are sometimes used to balance these effects.
Aggregated antibodies aren’t just bigger versions of the monomer. They often expose hydrophobic patches and altered charge distributions, which makes predicting chromatographic behavior difficult.
Why aggregates amplify secondary interactions
Compared to the monomer, HMW species (e.g. mAbs aggregates) often present altered surface properties (for example, exposed hydrophobic regions and redistributed charge), which increases the likelihood of adsorption and recovery loss. In SEC, that matters because even modest, non-size interactions can bias a quantitative aggregate profile, for example by selectively suppressing certain HMW species or broadening peaks.
Key SEC Method Development Parameters for mAb Aggregate Analysis
Key factors influencing monoclonal antibody aggregates analysis with SEC include column pore size, exclusion range, flow rate, and stationary-phase chemistry.
Column Pore Size and Exclusion Range
SEC columns rely on porous particles to separate molecules by hydrodynamic volume. For monoclonal antibody monomers and aggregates, pore sizes around 300 Å work well for most mAbs because they capture monomer and HMW variants, but pore-size needs can still shift depending on the antibody’s hydrodynamic profile. Larger aggregates elute near the void volume, while smaller species explore the pore network and elute later. Selecting the right exclusion range ensures your size variants separate rather than collapse into a single broad peak.
Impact of Flow Rate on Resolution
Flow rate in SEC affects resolution via mass transfer. The ideal flow rate provides the highest resolution because it gives molecules enough time to properly enter the particle pores fully but, without letting the longitudinal diffusion component prevail. Thus, if the flow rate is too low, excessive peak diffusion can occur, leading to reduced resolution. Conversely, high flow rates can lead to incomplete separation, causing proteins of different sizes to elute almost simultaneously and resulting in overlapping peaks in the chromatogram.
Column Chemistry and Silanol Activity
The stationary phase chemistry of an HPLC column, such as silica backbone and bonding chemistry, influences secondary interactions. Silica-based columns contain negatively charged silanol groups above pH 4.5.
Because many monoclonal antibodies have an isoelectric point (pI) above 7.0, they carry a net positive charge in standard SEC buffers. This leads to an undesirable ion-exchange effect where the protein binds to the stationary phase, resulting in increased retention times, severe peak tailing, and poor analyte recovery.
Diol-functionalized SEC packings are commonly used to improve column inertness for proteins. A covalently bonded, hydrophilic diol layer helps mask residual silanol activity and reduces nonspecific ionic and hydrophobic interactions, which can improve peak shape and recovery for mAbs and their HMW species (especially when secondary interactions are limiting method performance).
Mobile Phase Optimization - The Most Critical Factor in SEC mAb Methods
Mobile phase composition has one of the greatest effects on SEC performance for proteins. The composition of the mobile phase directly controls protein charge and solvation through ionic strength and pH, which govern electrostatic interactions with the column. It also influences hydrophobic behavior via salt type and concentration, making it the primary factor in minimizing unwanted secondary interactions and supporting true size-based separation.
Beyond controlling pH, salt identity and ionic strength are primary tools for suppressing electrostatic secondary interactions in protein SEC. Increasing ionic strength provides counterions that screen long-range electrostatic attraction and repulsion and can reduce ion-exchange-like adsorption of charged mAbs to residual charged sites on the packing surface, which otherwise manifests as tailing, retention shifts, or recovery loss. Because higher salt can also increase hydrophobic interactions for some antibodies, ionic strength is typically optimized to minimize electrostatics without introducing new adsorption or stability issues.
Limitations of Standard Mobile Phases
A “standard” mobile phase like 1X PBS is often used as a quick starting point for protein SEC, but it is not a reliable default for mAb aggregate analysis. In practice, performance depends strongly on the specific SEC surface chemistry, including the hydrophilic coating (typically a diol) and its bonded density. If the coating retains residual hydrophobic character, a kosmotropic buffer like phosphate can “salt out” the protein and increase hydrophobic secondary interactions, leading to band broadening and poor recovery of very hydrophobic HMW species.
On the other hand, if bonded density is lower and silanol activity is higher, electrostatic secondary interactions can dominate, and higher salt (NaCl, for example) may be needed to suppress those effects. Bottom line does not assume 1X PBS will behave consistently across mAbs and SEC columns.
Recommended Mobile Phase for mAb Aggregate Analysis
When developing a new SEC method for monoclonal antibodies, a reliable starting mobile phase is 50 mM potassium phosphate with 250 mM potassium chloride at pH 6.8. The higher ionic strength helps minimize electrostatic interactions while maintaining protein stability, and using potassium for both the buffer and salt is a practical choice for silica‑based SEC phases where some residual silanol activity may still be present.
From there, mobile phase optimizations like adjustments to salt concentration, pH, or additives can fine-tune peak shape, recovery, and robustness depending on the specific antibody and column chemistry.
Final Thoughts
SEC often gets positioned as a straightforward, size-based technique, but monoclonal antibodies tend to challenge that assumption. Surface chemistry, column design, and buffer composition all come into play, especially when you’re dealing with large aggregates.
Silica-based SEC columns with ~300 Å pores, such as Phenomenex Biozen SEC-3, provide a strong foundation for mAb aggregate analysis, but success ultimately comes from thoughtful method development rather than default conditions. With the right balance of column selection and mobile-phase optimization, SEC becomes a reliable and powerful tool for monitoring antibody aggregation throughout development.
If you want support developing your SEC method, submit a request through the Phenomenex Customer Support Portal.
